Stock Price Quote

KOPRAN LTD.

NSE : KOPRANBSE : 524280ISIN CODE : INE082A01010Industry : Pharmaceuticals & DrugsHouse : Parijat
BSE196.65-4.7 (-2.33 %)
PREV CLOSE ( ) 201.35
OPEN PRICE ( ) 197.30
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 12673
TODAY'S LOW / HIGH ( )195.70 199.75
52 WK LOW / HIGH ( )157 369.2
NSE196.47-4.98 (-2.47 %)
PREV CLOSE( ) 201.45
OPEN PRICE ( ) 199.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 196.47 (97)
VOLUME 233581
TODAY'S LOW / HIGH( ) 195.56 200.05
52 WK LOW / HIGH ( )155 369.7
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 1958
Management Info
Susheel G Somani - Chairman - Managing Director
Registered Office

Address Parijat House,1076 Dr E Moses Road,Worli,
Mumbai,
Maharashtra-400018

Phone 022- 43661111

Email cs@kopran.com

Website www.kopran.com

Registrars Details
Bigshare Services Pvt Ltd
Office No S6-2, 6th Floor, Pinnacle Business Park,Next to Ahura Centre, Mahakali Caves Road,Andheri (E),Mumbai
Listing : BSE, NSE

NEWS

16May Kopran informs about newspaper adverti
Pursuant to Regulation 47 of the SEBI (Listing Obligations and Disclosur..
29Apr USFDA concludes surveillance inspectio
U.S. Food and Drug Administration (USFDA) has concluded surveillance ins..
08Apr Kopran informs about compliance certif
Kopran has informed that it enclosed Compliance Certificate under Reg.74..
27Mar Kopran informs about trading window cl
Kopran has informed that the ‘Trading Window’ for dealing in the securit..
27Mar Kopran informs about recording of inve
With reference to Regulation 30 read with Part A of Schedule III and Reg..

Financials

in Millions
QTR Mar 25 ANNUAL 25
Net Profit85.9799999999998268.57
Gross Profit 117.07 357.95
Operating Profit 142.04445.6
Net Sales 759.352710.1

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Astrazeneca Pharma I (BSE)
peergroup  10524.65 (3.40%)
M.Cap ( in Cr)26311.63
RPG Life Sciences (BSE)
peergroup  2339.50 (4.07%)
M.Cap ( in Cr)3869.30
Abbott India (BSE)
peergroup  31545.15 (0.22%)
M.Cap ( in Cr)67031.24
Concord Biotech (BSE)
peergroup  2110.55 (2.44%)
M.Cap ( in Cr)22079.77
Onesource Specialty (BSE)
peergroup  2024.35 (2.45%)
M.Cap ( in Cr)23171.93

Shareholding Pattern

NON-INSTITUTION 54.45%
PROMOTERS 44.42%
FI/BANKS/INSURANCE 0%
MUTUAL FUNDS/UTI 0%
GOVERNMENT 0%
FII 0%

About Kopran Ltd.

Kopran Ltd. was incorporated in the year 1958. Its today's share price is 196.65. Its current market capitalisation stands at Rs 949.54 Cr. In the latest quarter, company has reported Gross Sales of Rs. 3374.79 Cr and Total Income of Rs.3542.22 Cr. The company's management includes Varun Somani, Sunita Banerji, Siddhan Subramanian, Narayan Atal, Mamta Biyani, Adarsh Somani, Surendra Somani, Susheel G Somani, Sunil Sodhani.

It is listed on the BSE with a BSE Code of 524280 , NSE with an NSE Symbol of KOPRAN and ISIN of INE082A01010. It's Registered office is at Parijat House,1076 Dr E Moses Road,WorliMumbai-400018, Maharashtra. Their Registrars are K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.) It's auditors are Batliboi & Purohit, Khandelwal Jain & Co

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.